Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-036133
Filing Date
2022-06-10
Accepted
2022-06-10 19:47:29
Documents
2
Period of Report
2022-06-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3944
2 POA DOCUMENT poa.txt EX-24 3254
  Complete submission text file 0001209191-22-036133.txt   8615
Mailing Address 12860 EL CAMINO REAL, SUITE 300 SAN DIEGO CA 92130
Business Address
Davis Aaron I. (Reporting) CIK: 0001465914 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39401 | Film No.: 221010402

Mailing Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472 857-204-4583
iTeos Therapeutics, Inc. (Issuer) CIK: 0001808865 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)